采用高效液相色谱法测定血浆中N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯基氨基]-4-吖啶甲酰胺的含量。 - Suppr | 超能文献

Determination of N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenylamino]-4 -acridinecarboxamide in plasma by high-performance liquid chromatography.

作者信息

Jurlina J L, Paxton J W

出版信息

J Chromatogr. 1985 Aug 9;342(2):431-5. doi: 10.1016/s0378-4347(00)84539-9.

DOI:10.1016/s0378-4347(00)84539-9

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Determination of N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenylamino]-4 -acridinecarboxamide in plasma by high-performance liquid chromatography.采用高效液相色谱法测定血浆中N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯基氨基]-4-吖啶甲酰胺的含量。

J Chromatogr. 1985 Aug 9;342(2):431-5. doi: 10.1016/s0378-4347(00)84539-9.

2

Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.氨吖啶新衍生物N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯氨基]-4-吖啶甲酰胺的合成、抗肿瘤活性及DNA结合特性

Cancer Res. 1984 Aug;44(8):3245-51.

3

The effect of food on the bioavailability and kinetics of the anticancer drug amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]-4 acridinecarboxamide in rabbits.食物对家兔体内抗癌药物安吖啶及其新类似物N-5-二甲基-9-[(2-甲氧基-4-甲磺酰氨基)苯氨基]-4-吖啶甲酰胺生物利用度和动力学的影响。

J Pharm Pharmacol. 1986 Nov;38(11):837-40. doi: 10.1111/j.2042-7158.1986.tb04505.x.

4

Comparison of the pharmacokinetics and protein binding of the anticancer drug, amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenyl-amino] -4-acridinecarboxamide in rabbits.抗癌药物安吖啶与一种新类似物N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯基氨基]-4-吖啶甲酰胺在兔体内的药代动力学及蛋白结合率比较

Cancer Chemother Pharmacol. 1986;16(3):253-6. doi: 10.1007/BF00293987.

5

Dose-dependent pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]- 4-acridinecarboxamide (CI-921) in rabbits.

Cancer Chemother Pharmacol. 1987;20(1):13-5. doi: 10.1007/BF00252952.

6

The binding of amsacrine to human plasma proteins.安吖啶与人血浆蛋白的结合。

J Pharm Pharmacol. 1986 Jun;38(6):432-8. doi: 10.1111/j.2042-7158.1986.tb04606.x.

7

Disposition of amsacrine and its analogue 9-([2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921) in plasma, liver, and Lewis lung tumors in mice.氨吖啶及其类似物9-([2-甲氧基-4-[(甲基磺酰基)氨基]苯基]氨基)-N,5-二甲基-4-吖啶甲酰胺（CI-921）在小鼠血浆、肝脏和Lewis肺癌中的分布。

Cancer Res. 1990 Feb 1;50(3):503-8.

8

Effects of a new amsacrine derivative, N-5-dimethyl-9-(2-methoxy-4-methylsulfonylamino)phenylamino-4- acridinecarboxamide, on cultured mammalian cells.

Cancer Res. 1987 Jan 15;47(2):424-32.

9

Development and validation of bioanalytical method for the determination of asulacrine in plasma by liquid chromatography.液相色谱法测定血浆中阿苏克林的生物分析方法的建立与验证

J Pharm Biomed Anal. 2008 Jan 22;46(2):386-90. doi: 10.1016/j.jpba.2007.09.025. Epub 2007 Oct 2.

10

The effect of cimetidine, phenobarbitone and buthionine sulphoximine on the disposition of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulphonylamino)phenylamino]- 4-acridinecarboxamide (CI-921) in the rabbit.

Cancer Chemother Pharmacol. 1989;23(5):291-5. doi: 10.1007/BF00292406.

引用本文的文献

1

Comparison of the pharmacokinetics and protein binding of the anticancer drug, amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenyl-amino] -4-acridinecarboxamide in rabbits.抗癌药物安吖啶与一种新类似物N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯基氨基]-4-吖啶甲酰胺在兔体内的药代动力学及蛋白结合率比较

Cancer Chemother Pharmacol. 1986;16(3):253-6. doi: 10.1007/BF00293987.

2

Dose-dependent pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]- 4-acridinecarboxamide (CI-921) in rabbits.

Cancer Chemother Pharmacol. 1987;20(1):13-5. doi: 10.1007/BF00252952.

3

The clinical pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulfonylamino)phenylamino]-4 -acridinecarboxamide (CI-921) in a phase 1 trial.N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯基氨基]-4-吖啶甲酰胺（CI-921）在1期试验中的临床药代动力学

Cancer Chemother Pharmacol. 1988;22(3):235-40. doi: 10.1007/BF00273417.

4

The effect of cimetidine, phenobarbitone and buthionine sulphoximine on the disposition of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulphonylamino)phenylamino]- 4-acridinecarboxamide (CI-921) in the rabbit.

Cancer Chemother Pharmacol. 1989;23(5):291-5. doi: 10.1007/BF00292406.